data_1fks_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fks _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.423 ' O ' ' OG ' ' A' ' 77' ' ' SER . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.767 -1.333 . . . . 1.72 109.767 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.63 150.33 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 109.912 -0.403 . . . . 0.05 109.912 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -122.82 155.63 36.19 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 106.943 -1.502 . . . . 6.21 106.943 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.19 105.77 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.205 -1.035 . . . . 0.12 108.205 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -107.15 102.83 12.13 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.879 -1.526 . . . . 6.39 106.879 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.3 m -79.4 154.0 29.3 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.438 1.113 . . . . 0.08 112.623 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -123.23 -51.39 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 112.757 -2.019 . . . . 0.13 107.429 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 9' ' ' PRO . 47.4 t -122.69 80.45 48.33 Favored Pre-proline 0 N--CA 1.504 2.262 0 CA-C-N 115.098 -0.955 . . . . 1.46 112.316 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.4 Cg_exo -37.33 164.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.555 2.17 . . . . 0.09 112.944 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.82 -171.98 14.47 Favored Glycine 0 N--CA 1.501 3.019 0 N-CA-C 105.619 -2.992 . . . . 0.27 105.619 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 12' ' ' GLY . 14.9 p-10 -44.95 -55.43 5.5 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 118.558 1.179 . . . . 1.62 110.635 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 11' ' ' ASP . . . 109.02 5.4 30.78 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.547 -1.021 . . . . 0.26 110.547 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -126.98 -17.1 4.95 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.971 1.101 . . . . 9.68 113.971 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.0 m -113.66 120.49 41.05 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 119.569 1.077 . . . . 0.12 108.988 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 28.7 m-85 -124.81 175.08 3.22 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 108.384 -0.969 . . . . 1.95 108.384 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -65.3 145.21 83.09 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 CA-C-N 119.705 0.931 . . . . 0.24 111.613 166.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -119.43 171.62 8.21 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.836 0.827 . . . . 4.98 109.798 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -74.99 105.47 6.02 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.802 -1.09 . . . . 12.72 110.826 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.22 3.33 13.11 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 108.411 -1.876 . . . . 0.31 108.411 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -107.91 172.21 6.96 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.088 -1.078 . . . . 2.84 108.088 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -118.86 149.09 42.13 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 101.024 -3.695 . . . . 0.53 101.024 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -108.5 141.82 39.81 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 102.594 -3.113 . . . . 0.16 102.594 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.76 101.23 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 102.009 -3.33 . . . . 0.09 102.009 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.28 152.02 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 114.801 1.408 . . . . 0.09 114.801 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.645 ' HD1' ' N ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -129.34 118.41 22.2 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 103.751 -2.685 . . . . 1.81 103.751 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.645 ' N ' ' HD1' ' A' ' 25' ' ' HIS . 46.3 p90 -134.68 173.02 12.14 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 123.13 1.443 . . . . 1.67 114.614 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -132.74 117.7 18.14 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 102.888 -3.004 . . . . 0.15 102.888 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.06 134.31 11.64 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.56 -1.816 . . . . 0.37 108.56 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.5 ttm -136.28 172.75 12.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.839 -1.541 . . . . 3.79 106.839 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -118.91 161.55 20.0 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 104.752 -2.314 . . . . 1.27 104.752 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -27.79 -56.08 0.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 115.371 1.619 . . . . 7.77 115.371 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -159.33 43.91 0.24 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.483 -1.287 . . . . 8.38 110.579 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.78 -84.79 0.89 Allowed Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.173 -1.489 . . . . 2.84 110.874 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' CD ' ' N ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -161.06 -166.45 1.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.172 -1.014 . . . . 11.87 113.291 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -90.63 137.35 32.43 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.32 -1.363 . . . . 9.51 107.32 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CD2' ' OD2' ' A' ' 37' ' ' ASP . 3.1 p90 -121.32 -37.19 2.96 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.043 -1.89 . . . . 1.84 107.515 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.525 ' OD2' ' CD2' ' A' ' 36' ' ' PHE . 46.8 m-20 -138.62 91.28 2.52 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-N 115.128 -0.942 . . . . 2.66 112.933 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 m -109.14 167.36 10.16 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.522 ' OG ' ' ND1' ' A' ' 25' ' ' HIS . 62.2 p -119.3 61.77 0.81 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.501 -0.925 . . . . 2.02 108.501 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.02 59.25 0.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 125.334 2.492 . . . . 40.28 105.857 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.39 117.25 29.51 Favored 'General case' 0 C--N 1.307 -1.264 1 CA-C-N 107.066 -4.606 . . . . 29.2 108.614 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.549 ' CD ' ' H ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -17.37 -76.77 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 110.865 -2.879 . . . . 68.65 114.639 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -111.01 -37.06 5.48 Favored 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 116.534 2.05 . . . . 20.71 116.534 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' PRO . 64.2 mttm -108.2 113.16 60.88 Favored Pre-proline 0 N--CA 1.5 2.064 0 CA-C-O 118.88 -0.581 . . . . 14.87 111.831 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 36.7 Cg_exo -44.53 -156.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.95 1.767 . . . . 0.88 111.637 161.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -102.66 143.9 31.73 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.472 -1.694 . . . . 0.51 110.24 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -132.81 124.27 27.72 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 112.707 0.632 . . . . 3.76 112.707 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -138.32 172.67 12.55 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 119.321 -0.952 . . . . 1.57 111.452 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -117.0 147.55 42.21 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.3 0.571 . . . . 2.45 112.252 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 tp -91.08 122.6 33.87 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.336 -0.847 . . . . 0.33 112.422 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.62 12.05 23.7 Favored Glycine 0 N--CA 1.502 3.035 0 N-CA-C 111.636 -0.586 . . . . 0.94 111.636 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -125.39 -11.35 6.88 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.037 0.446 . . . . 8.93 109.921 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 55.31 71.67 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.672 0.748 . . . . 5.97 111.57 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -106.67 -29.72 9.42 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 105.746 -1.946 . . . . 6.35 105.746 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.95 156.3 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.603 -1.258 . . . . 0.29 107.603 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.3 pt -56.1 176.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 118.501 -1.28 . . . . 0.31 108.726 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' TRP . 23.2 ttm-85 -69.58 -60.36 2.37 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 119.91 -0.716 . . . . 9.62 110.638 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.42 -36.62 0.01 OUTLIER Glycine 0 N--CA 1.503 3.103 0 O-C-N 124.854 1.346 . . . . 0.08 111.586 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -78.27 -75.95 0.21 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 105.862 -1.903 . . . . 0.12 105.862 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -28.13 -55.69 0.11 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.659 -1.61 . . . . 3.9 110.725 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -70.85 -52.2 21.82 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.573 -1.639 . . . . 3.69 106.573 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -58.31 -74.75 0.31 Allowed Glycine 0 N--CA 1.479 1.513 0 C-N-CA 120.069 -1.062 . . . . 0.07 112.101 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 59' ' ' TRP . 29.4 t -41.45 -50.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.644 -0.822 . . . . 0.06 112.25 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.63 -61.52 1.67 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.958 1.837 . . . . 0.1 111.258 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -48.61 -11.43 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 109.799 -3.364 . . . . 0.08 109.33 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.516 ' H ' ' C ' ' A' ' 64' ' ' ALA . 91.8 mtp -97.71 157.93 15.79 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 118.287 -1.365 . . . . 1.77 108.615 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.4 p -115.85 150.75 36.52 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 122.856 1.312 . . . . 0.07 112.943 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.8 t -45.38 99.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 112.304 -2.226 . . . . 0.06 114.409 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.11 8.24 22.11 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 109.499 -1.44 . . . . 0.06 109.499 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -107.27 147.03 30.73 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 121.769 0.795 . . . . 1.59 110.992 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -130.24 140.81 50.67 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.173 -1.376 . . . . 6.18 108.473 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.85 177.53 9.46 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 112.854 -1.975 . . . . 0.04 114.743 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HZ1' ' CB ' ' A' ' 73' ' ' LYS . 7.2 ttpm? -123.27 104.6 9.24 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 102.738 -3.06 . . . . 4.65 102.738 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mt -94.89 151.36 19.28 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.427 -0.806 . . . . 1.04 109.002 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.3 m -122.57 114.64 20.92 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 104.911 -2.255 . . . . 0.11 104.911 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -106.87 135.55 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.091 -0.707 . . . . 0.08 109.091 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 43.4 p -105.63 154.52 39.15 Favored Pre-proline 0 N--CA 1.5 2.062 0 CA-C-N 113.922 -1.49 . . . . 0.5 108.357 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -37.73 -53.21 1.53 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.032 1.821 . . . . 0.31 113.86 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 10.5 p-10 -42.82 -38.84 2.28 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.169 -0.923 . . . . 1.63 113.317 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -99.57 -18.2 17.48 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.661 -0.7 . . . . 1.77 112.482 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.95 -114.31 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.83 -1.148 . . . . 2.03 111.141 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -113.73 69.25 0.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 105.945 -1.872 . . . . 3.42 105.945 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 21.38 -114.96 0.01 OUTLIER Glycine 0 N--CA 1.496 2.694 0 O-C-N 125.519 1.762 . . . . 4.82 114.025 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -118.75 -18.75 8.88 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.365 0.602 . . . . 6.86 109.669 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.0 m -114.31 87.98 2.75 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.229 -0.896 . . . . 12.67 110.903 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.62 -90.68 1.97 Allowed Glycine 0 N--CA 1.497 2.755 0 N-CA-C 106.927 -2.469 . . . . 5.68 106.927 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.413 ' O ' ' O ' ' A' ' 91' ' ' ILE . 39.4 t60 -163.74 132.81 2.93 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 118.711 -1.195 . . . . 18.56 108.05 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.47 108.59 2.72 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.771 1.647 . . . . 8.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.1 -36.59 2.12 Favored Glycine 0 N--CA 1.504 3.169 0 C-N-CA 120.842 -0.694 . . . . 3.19 112.174 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 mt -109.06 -59.42 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 106.121 -1.807 . . . . 2.0 106.121 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' ' 87' ' ' HIS . 2.1 mt -118.02 93.75 45.1 Favored Pre-proline 0 N--CA 1.501 2.08 0 CA-C-N 112.785 -2.007 . . . . 1.41 107.391 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.19 165.73 6.75 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.547 2.165 . . . . 1.58 107.952 166.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 94' ' ' HIS . 31.3 Cg_endo -50.64 175.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.718 1.612 . . . . 1.94 109.95 173.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 93' ' ' PRO . 12.5 m80 9.54 64.47 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 125.842 1.964 . . . . 11.93 113.802 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.32 77.49 1.11 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.791 1.404 . . . . 1.5 114.791 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 96.1 m -33.2 126.83 0.34 Allowed 'General case' 0 N--CA 1.506 2.354 0 O-C-N 124.181 0.926 . . . . 0.22 110.506 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 mt -102.03 153.46 19.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.866 -1.531 . . . . 0.3 106.866 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.67 118.77 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.525 -1.287 . . . . 0.21 107.525 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -110.77 156.9 20.42 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.56 0.695 . . . . 1.18 109.296 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -124.94 89.64 3.1 Favored 'General case' 0 N--CA 1.493 1.714 1 N-CA-C 97.499 -5.0 . . . . 1.74 97.499 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.4 t -104.18 147.77 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 115.535 1.68 . . . . 0.05 115.535 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -125.16 105.33 9.07 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.149 -2.296 . . . . 1.73 106.735 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.4 tp -74.99 121.76 22.45 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 100.866 -3.753 . . . . 0.04 100.866 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.41 -54.95 3.7 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.385 -0.825 . . . . 0.34 112.905 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -166.36 177.6 6.69 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.775 -1.17 . . . . 7.5 110.314 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.9 mt -112.62 157.27 21.42 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 105.363 -2.088 . . . . 0.44 105.363 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.502 2.144 0 CA-C-O 116.141 -1.885 . . . . 6.58 109.744 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.767 -1.333 . . . . 1.72 109.767 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.63 150.33 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 109.912 -0.403 . . . . 0.050000000000000003 109.912 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -122.82 155.63 36.19 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 106.943 -1.502 . . . . 6.21 106.943 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.19 105.77 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.205 -1.035 . . . . 0.12 108.205 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -107.15 102.83 12.13 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.879 -1.526 . . . . 6.3899999999999997 106.879 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.3 m -79.4 154.0 29.3 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.438 1.113 . . . . 0.080000000000000002 112.623 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -123.23 -51.39 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 112.757 -2.019 . . . . 0.13 107.429 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 9' ' ' PRO . 47.4 t -122.69 80.45 48.33 Favored Pre-proline 0 N--CA 1.504 2.262 0 CA-C-N 115.098 -0.955 . . . . 1.46 112.316 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.4 Cg_exo -37.33 164.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.555 2.17 . . . . 0.089999999999999997 112.944 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.82 -171.98 14.47 Favored Glycine 0 N--CA 1.501 3.019 0 N-CA-C 105.619 -2.992 . . . . 0.27000000000000002 105.619 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -44.95 -55.43 5.5 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 118.558 1.179 . . . . 1.6200000000000001 110.635 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.02 5.4 30.78 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.547 -1.021 . . . . 0.26000000000000001 110.547 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -126.98 -17.1 4.95 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.971 1.101 . . . . 9.6799999999999997 113.971 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.0 m -113.66 120.49 41.05 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 119.569 1.077 . . . . 0.12 108.988 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 28.7 m-85 -124.81 175.08 3.22 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 108.384 -0.969 . . . . 1.95 108.384 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -65.3 145.21 83.09 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 CA-C-N 119.705 0.931 . . . . 0.23999999999999999 111.613 166.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -119.43 171.62 8.21 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.836 0.827 . . . . 4.9800000000000004 109.798 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -74.99 105.47 6.02 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.802 -1.09 . . . . 12.720000000000001 110.826 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.22 3.33 13.11 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 108.411 -1.876 . . . . 0.31 108.411 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -107.91 172.21 6.96 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.088 -1.078 . . . . 2.8399999999999999 108.088 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -118.86 149.09 42.13 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 101.024 -3.695 . . . . 0.53000000000000003 101.024 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -108.5 141.82 39.81 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 102.594 -3.113 . . . . 0.16 102.594 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.76 101.23 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 102.009 -3.33 . . . . 0.089999999999999997 102.009 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.28 152.02 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 114.801 1.408 . . . . 0.089999999999999997 114.801 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' ND1' ' OG ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -129.34 118.41 22.2 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 103.751 -2.685 . . . . 1.8100000000000001 103.751 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.428 ' O ' ' OG ' ' A' ' 39' ' ' SER . 46.3 p90 -134.68 173.02 12.14 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 123.13 1.443 . . . . 1.6699999999999999 114.614 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -132.74 117.7 18.14 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 102.888 -3.004 . . . . 0.14999999999999999 102.888 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.06 134.31 11.64 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.56 -1.816 . . . . 0.37 108.56 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.5 ttm -136.28 172.75 12.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.839 -1.541 . . . . 3.79 106.839 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -118.91 161.55 20.0 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 104.752 -2.314 . . . . 1.27 104.752 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -27.79 -56.08 0.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 115.371 1.619 . . . . 7.7699999999999996 115.371 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -159.33 43.91 0.24 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.483 -1.287 . . . . 8.3800000000000008 110.579 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.78 -84.79 0.89 Allowed Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.173 -1.489 . . . . 2.8399999999999999 110.874 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' CD ' ' N ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -161.06 -166.45 1.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.172 -1.014 . . . . 11.869999999999999 113.291 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 21.0 pttp -90.63 137.35 32.43 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.32 -1.363 . . . . 9.5099999999999998 107.32 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CD2' ' OD2' ' A' ' 37' ' ' ASP . 3.1 p90 -121.32 -37.19 2.96 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.043 -1.89 . . . . 1.8400000000000001 107.515 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.525 ' OD2' ' CD2' ' A' ' 36' ' ' PHE . 46.8 m-20 -138.62 91.28 2.52 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-N 115.128 -0.942 . . . . 2.6600000000000001 112.933 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 m -109.14 167.36 10.16 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.522 ' OG ' ' ND1' ' A' ' 25' ' ' HIS . 62.2 p -119.3 61.77 0.81 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.501 -0.925 . . . . 2.02 108.501 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.433 ' H ' ' HG3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -106.02 59.25 0.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 125.334 2.492 . . . . 40.280000000000001 105.857 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.39 117.25 29.51 Favored 'General case' 0 C--N 1.307 -1.264 1 CA-C-N 107.066 -4.606 . . . . 29.199999999999999 108.614 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.696 ' H ' ' CD ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -17.37 -76.77 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 110.865 -2.879 . . . . 68.650000000000006 114.639 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -111.01 -37.06 5.48 Favored 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 116.534 2.05 . . . . 20.710000000000001 116.534 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' PRO . 64.2 mttm -108.2 113.16 60.88 Favored Pre-proline 0 N--CA 1.5 2.064 0 CA-C-O 118.88 -0.581 . . . . 14.869999999999999 111.831 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 36.7 Cg_exo -44.53 -156.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.95 1.767 . . . . 0.88 111.637 161.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -102.66 143.9 31.73 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.472 -1.694 . . . . 0.51000000000000001 110.24 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -132.81 124.27 27.72 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 112.707 0.632 . . . . 3.7599999999999998 112.707 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -138.32 172.67 12.55 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 119.321 -0.952 . . . . 1.5700000000000001 111.452 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -117.0 147.55 42.21 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.3 0.571 . . . . 2.4500000000000002 112.252 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 tp -91.08 122.6 33.87 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.336 -0.847 . . . . 0.33000000000000002 112.422 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.62 12.05 23.7 Favored Glycine 0 N--CA 1.502 3.035 0 N-CA-C 111.636 -0.586 . . . . 0.93999999999999995 111.636 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -125.39 -11.35 6.88 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.037 0.446 . . . . 8.9299999999999997 109.921 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 55.31 71.67 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.672 0.748 . . . . 5.9699999999999998 111.57 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -106.67 -29.72 9.42 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 105.746 -1.946 . . . . 6.3499999999999996 105.746 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.95 156.3 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.603 -1.258 . . . . 0.28999999999999998 107.603 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.3 pt -56.1 176.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 118.501 -1.28 . . . . 0.31 108.726 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' TRP . 23.2 ttm-85 -69.58 -60.36 2.37 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 119.91 -0.716 . . . . 9.6199999999999992 110.638 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.42 -36.62 0.01 OUTLIER Glycine 0 N--CA 1.503 3.103 0 O-C-N 124.854 1.346 . . . . 0.080000000000000002 111.586 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -78.27 -75.95 0.21 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 105.862 -1.903 . . . . 0.12 105.862 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -28.13 -55.69 0.11 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.659 -1.61 . . . . 3.8999999999999999 110.725 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -70.85 -52.2 21.82 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.573 -1.639 . . . . 3.6899999999999999 106.573 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -58.31 -74.75 0.31 Allowed Glycine 0 N--CA 1.479 1.513 0 C-N-CA 120.069 -1.062 . . . . 0.070000000000000007 112.101 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 59' ' ' TRP . 29.4 t -41.45 -50.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.644 -0.822 . . . . 0.059999999999999998 112.25 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.63 -61.52 1.67 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.958 1.837 . . . . 0.10000000000000001 111.258 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.61 -11.43 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 109.799 -3.364 . . . . 0.080000000000000002 109.33 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 91.8 mtp -97.71 157.93 15.79 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 118.287 -1.365 . . . . 1.77 108.615 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.4 p -115.85 150.75 36.52 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 122.856 1.312 . . . . 0.070000000000000007 112.943 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.8 t -45.38 99.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 112.304 -2.226 . . . . 0.059999999999999998 114.409 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.11 8.24 22.11 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 109.499 -1.44 . . . . 0.059999999999999998 109.499 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -107.27 147.03 30.73 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 121.769 0.795 . . . . 1.5900000000000001 110.992 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -130.24 140.81 50.67 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.173 -1.376 . . . . 6.1799999999999997 108.473 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.85 177.53 9.46 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 112.854 -1.975 . . . . 0.040000000000000001 114.743 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -123.27 104.6 9.24 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 102.738 -3.06 . . . . 4.6500000000000004 102.738 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mt -94.89 151.36 19.28 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.427 -0.806 . . . . 1.04 109.002 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.3 m -122.57 114.64 20.92 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 104.911 -2.255 . . . . 0.11 104.911 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -106.87 135.55 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.091 -0.707 . . . . 0.080000000000000002 109.091 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 43.4 p -105.63 154.52 39.15 Favored Pre-proline 0 N--CA 1.5 2.062 0 CA-C-N 113.922 -1.49 . . . . 0.5 108.357 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -37.73 -53.21 1.53 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.032 1.821 . . . . 0.31 113.86 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 10.5 p-10 -42.82 -38.84 2.28 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.169 -0.923 . . . . 1.6299999999999999 113.317 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -99.57 -18.2 17.48 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.661 -0.7 . . . . 1.77 112.482 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.95 -114.31 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.83 -1.148 . . . . 2.0299999999999998 111.141 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -113.73 69.25 0.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 105.945 -1.872 . . . . 3.4199999999999999 105.945 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 21.38 -114.96 0.01 OUTLIER Glycine 0 N--CA 1.496 2.694 0 O-C-N 125.519 1.762 . . . . 4.8200000000000003 114.025 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -118.75 -18.75 8.88 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.365 0.602 . . . . 6.8600000000000003 109.669 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.0 m -114.31 87.98 2.75 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.229 -0.896 . . . . 12.67 110.903 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.62 -90.68 1.97 Allowed Glycine 0 N--CA 1.497 2.755 0 N-CA-C 106.927 -2.469 . . . . 5.6799999999999997 106.927 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.413 ' O ' ' O ' ' A' ' 91' ' ' ILE . 39.4 t60 -163.74 132.81 2.93 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 118.711 -1.195 . . . . 18.559999999999999 108.05 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.47 108.59 2.72 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.771 1.647 . . . . 8.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.1 -36.59 2.12 Favored Glycine 0 N--CA 1.504 3.169 0 C-N-CA 120.842 -0.694 . . . . 3.1899999999999999 112.174 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 mt -109.06 -59.42 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 106.121 -1.807 . . . . 2.0 106.121 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' ' 87' ' ' HIS . 2.1 mt -118.02 93.75 45.1 Favored Pre-proline 0 N--CA 1.501 2.08 0 CA-C-N 112.785 -2.007 . . . . 1.4099999999999999 107.391 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.19 165.73 6.75 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.547 2.165 . . . . 1.5800000000000001 107.952 166.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 94' ' ' HIS . 31.3 Cg_endo -50.64 175.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.718 1.612 . . . . 1.9399999999999999 109.95 173.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 93' ' ' PRO . 12.5 m80 9.54 64.47 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 125.842 1.964 . . . . 11.93 113.802 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.32 77.49 1.11 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.791 1.404 . . . . 1.5 114.791 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 96.1 m -33.2 126.83 0.34 Allowed 'General case' 0 N--CA 1.506 2.354 0 O-C-N 124.181 0.926 . . . . 0.22 110.506 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 mt -102.03 153.46 19.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.866 -1.531 . . . . 0.29999999999999999 106.866 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.67 118.77 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.525 -1.287 . . . . 0.20999999999999999 107.525 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -110.77 156.9 20.42 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.56 0.695 . . . . 1.1799999999999999 109.296 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -124.94 89.64 3.1 Favored 'General case' 0 N--CA 1.493 1.714 1 N-CA-C 97.499 -5.0 . . . . 1.74 97.499 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.4 t -104.18 147.77 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 115.535 1.68 . . . . 0.050000000000000003 115.535 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -125.16 105.33 9.07 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.149 -2.296 . . . . 1.73 106.735 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.4 tp -74.99 121.76 22.45 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 100.866 -3.753 . . . . 0.040000000000000001 100.866 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.41 -54.95 3.7 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.385 -0.825 . . . . 0.34000000000000002 112.905 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -166.36 177.6 6.69 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.775 -1.17 . . . . 7.5 110.314 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.9 mt -112.62 157.27 21.42 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 105.363 -2.088 . . . . 0.44 105.363 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.502 2.144 0 CA-C-O 116.141 -1.885 . . . . 6.5800000000000001 109.744 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.767 -1.333 . . . . 1.72 109.767 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.63 150.33 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 109.912 -0.403 . . . . 0.05 109.912 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -122.82 155.63 36.19 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 106.943 -1.502 . . . . 6.21 106.943 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.19 105.77 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.205 -1.035 . . . . 0.12 108.205 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -107.15 102.83 12.13 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 106.879 -1.526 . . . . 6.39 106.879 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.3 m -79.4 154.0 29.3 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.438 1.113 . . . . 0.08 112.623 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -123.23 -51.39 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 112.757 -2.019 . . . . 0.13 107.429 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 9' ' ' PRO . 47.4 t -122.69 80.45 48.33 Favored Pre-proline 0 N--CA 1.504 2.262 0 CA-C-N 115.098 -0.955 . . . . 1.46 112.316 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.4 Cg_exo -37.33 164.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.555 2.17 . . . . 0.09 112.944 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.82 -171.98 14.47 Favored Glycine 0 N--CA 1.501 3.019 0 N-CA-C 105.619 -2.992 . . . . 0.27 105.619 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -44.95 -55.43 5.5 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 118.558 1.179 . . . . 1.62 110.635 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.02 5.4 30.78 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.547 -1.021 . . . . 0.26 110.547 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -126.98 -17.1 4.95 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 113.971 1.101 . . . . 9.68 113.971 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.0 m -113.66 120.49 41.05 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 119.569 1.077 . . . . 0.12 108.988 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 15' ' ' PHE . 28.7 m-85 -124.81 175.08 3.22 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 108.384 -0.969 . . . . 1.95 108.384 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -65.3 145.21 83.09 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 CA-C-N 119.705 0.931 . . . . 0.24 111.613 166.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -119.43 171.62 8.21 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.836 0.827 . . . . 4.98 109.798 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -74.99 105.47 6.02 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.802 -1.09 . . . . 12.72 110.826 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.22 3.33 13.11 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 108.411 -1.876 . . . . 0.31 108.411 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -107.91 172.21 6.96 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.088 -1.078 . . . . 2.84 108.088 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -118.86 149.09 42.13 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 101.024 -3.695 . . . . 0.53 101.024 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -108.5 141.82 39.81 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 102.594 -3.113 . . . . 0.16 102.594 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.76 101.23 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 102.009 -3.33 . . . . 0.09 102.009 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.28 152.02 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 114.801 1.408 . . . . 0.09 114.801 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' ND1' ' OG ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -129.34 118.41 22.2 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 103.751 -2.685 . . . . 1.81 103.751 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.428 ' O ' ' OG ' ' A' ' 39' ' ' SER . 46.3 p90 -134.68 173.02 12.14 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 123.13 1.443 . . . . 1.67 114.614 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -132.74 117.7 18.14 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 102.888 -3.004 . . . . 0.15 102.888 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.06 134.31 11.64 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.56 -1.816 . . . . 0.37 108.56 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 42.5 ttm -136.28 172.75 12.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.839 -1.541 . . . . 3.79 106.839 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -118.91 161.55 20.0 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 104.752 -2.314 . . . . 1.27 104.752 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -27.79 -56.08 0.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 115.371 1.619 . . . . 7.77 115.371 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -159.33 43.91 0.24 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.483 -1.287 . . . . 8.38 110.579 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.78 -84.79 0.89 Allowed Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.173 -1.489 . . . . 2.84 110.874 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' CD ' ' N ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -161.06 -166.45 1.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 114.172 -1.014 . . . . 11.87 113.291 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 21.0 pttp -90.63 137.35 32.43 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.32 -1.363 . . . . 9.51 107.32 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CD2' ' OD2' ' A' ' 37' ' ' ASP . 3.1 p90 -121.32 -37.19 2.96 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.043 -1.89 . . . . 1.84 107.515 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.525 ' OD2' ' CD2' ' A' ' 36' ' ' PHE . 46.8 m-20 -138.62 91.28 2.52 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-N 115.128 -0.942 . . . . 2.66 112.933 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 m -109.14 167.36 10.16 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.522 ' OG ' ' ND1' ' A' ' 25' ' ' HIS . 62.2 p -119.3 61.77 0.81 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.501 -0.925 . . . . 2.02 108.501 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.433 ' H ' ' HG3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -106.02 59.25 0.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 125.334 2.492 . . . . 40.28 105.857 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.39 117.25 29.51 Favored 'General case' 0 C--N 1.307 -1.264 1 CA-C-N 107.066 -4.606 . . . . 29.2 108.614 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.696 ' CD ' ' H ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -17.37 -76.77 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 110.865 -2.879 . . . . 68.65 114.639 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -111.01 -37.06 5.48 Favored 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 116.534 2.05 . . . . 20.71 116.534 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 45' ' ' PRO . 64.2 mttm -108.2 113.16 60.88 Favored Pre-proline 0 N--CA 1.5 2.064 0 CA-C-O 118.88 -0.581 . . . . 14.87 111.831 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 36.7 Cg_exo -44.53 -156.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.95 1.767 . . . . 0.88 111.637 161.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -102.66 143.9 31.73 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.472 -1.694 . . . . 0.51 110.24 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -132.81 124.27 27.72 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 112.707 0.632 . . . . 3.76 112.707 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -138.32 172.67 12.55 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 119.321 -0.952 . . . . 1.57 111.452 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -117.0 147.55 42.21 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.3 0.571 . . . . 2.45 112.252 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 tp -91.08 122.6 33.87 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.336 -0.847 . . . . 0.33 112.422 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.62 12.05 23.7 Favored Glycine 0 N--CA 1.502 3.035 0 N-CA-C 111.636 -0.586 . . . . 0.94 111.636 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -125.39 -11.35 6.88 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.037 0.446 . . . . 8.93 109.921 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 55.31 71.67 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.672 0.748 . . . . 5.97 111.57 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -106.67 -29.72 9.42 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 105.746 -1.946 . . . . 6.35 105.746 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.95 156.3 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.603 -1.258 . . . . 0.29 107.603 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.3 pt -56.1 176.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 118.501 -1.28 . . . . 0.31 108.726 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' TRP . 23.2 ttm-85 -69.58 -60.36 2.37 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 119.91 -0.716 . . . . 9.62 110.638 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -27.42 -36.62 0.01 OUTLIER Glycine 0 N--CA 1.503 3.103 0 O-C-N 124.854 1.346 . . . . 0.08 111.586 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -78.27 -75.95 0.21 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 105.862 -1.903 . . . . 0.12 105.862 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -28.13 -55.69 0.11 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.659 -1.61 . . . . 3.9 110.725 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -70.85 -52.2 21.82 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.573 -1.639 . . . . 3.69 106.573 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . -58.31 -74.75 0.31 Allowed Glycine 0 N--CA 1.479 1.513 0 C-N-CA 120.069 -1.062 . . . . 0.07 112.101 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 59' ' ' TRP . 29.4 t -41.45 -50.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.644 -0.822 . . . . 0.06 112.25 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 66' ' ' MET . . . -45.63 -61.52 1.67 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 123.958 1.837 . . . . 0.1 111.258 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -48.61 -11.43 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 109.799 -3.364 . . . . 0.08 109.33 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 64' ' ' ALA . 91.8 mtp -97.71 157.93 15.79 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 118.287 -1.365 . . . . 1.77 108.615 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.4 p -115.85 150.75 36.52 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-O 122.856 1.312 . . . . 0.07 112.943 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.8 t -45.38 99.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 112.304 -2.226 . . . . 0.06 114.409 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.11 8.24 22.11 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 109.499 -1.44 . . . . 0.06 109.499 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -107.27 147.03 30.73 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 121.769 0.795 . . . . 1.59 110.992 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -130.24 140.81 50.67 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.173 -1.376 . . . . 6.18 108.473 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.85 177.53 9.46 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 112.854 -1.975 . . . . 0.04 114.743 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -123.27 104.6 9.24 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 102.738 -3.06 . . . . 4.65 102.738 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mt -94.89 151.36 19.28 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.427 -0.806 . . . . 1.04 109.002 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.3 m -122.57 114.64 20.92 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 104.911 -2.255 . . . . 0.11 104.911 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -106.87 135.55 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.091 -0.707 . . . . 0.08 109.091 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 79' ' ' ASP . 43.4 p -105.63 154.52 39.15 Favored Pre-proline 0 N--CA 1.5 2.062 0 CA-C-N 113.922 -1.49 . . . . 0.5 108.357 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -37.73 -53.21 1.53 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.032 1.821 . . . . 0.31 113.86 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 10.5 p-10 -42.82 -38.84 2.28 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.169 -0.923 . . . . 1.63 113.317 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -99.57 -18.2 17.48 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.661 -0.7 . . . . 1.77 112.482 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.95 -114.31 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.83 -1.148 . . . . 2.03 111.141 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -113.73 69.25 0.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 105.945 -1.872 . . . . 3.42 105.945 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 21.38 -114.96 0.01 OUTLIER Glycine 0 N--CA 1.496 2.694 0 O-C-N 125.519 1.762 . . . . 4.82 114.025 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -118.75 -18.75 8.88 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.365 0.602 . . . . 6.86 109.669 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.0 m -114.31 87.98 2.75 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.229 -0.896 . . . . 12.67 110.903 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.62 -90.68 1.97 Allowed Glycine 0 N--CA 1.497 2.755 0 N-CA-C 106.927 -2.469 . . . . 5.68 106.927 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.413 ' O ' ' O ' ' A' ' 91' ' ' ILE . 39.4 t60 -163.74 132.81 2.93 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 118.711 -1.195 . . . . 18.56 108.05 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.47 108.59 2.72 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.771 1.647 . . . . 8.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.1 -36.59 2.12 Favored Glycine 0 N--CA 1.504 3.169 0 C-N-CA 120.842 -0.694 . . . . 3.19 112.174 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 mt -109.06 -59.42 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 106.121 -1.807 . . . . 2.0 106.121 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.413 ' O ' ' O ' ' A' ' 87' ' ' HIS . 2.1 mt -118.02 93.75 45.1 Favored Pre-proline 0 N--CA 1.501 2.08 0 CA-C-N 112.785 -2.007 . . . . 1.41 107.391 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.19 165.73 6.75 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.547 2.165 . . . . 1.58 107.952 166.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 94' ' ' HIS . 31.3 Cg_endo -50.64 175.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.718 1.612 . . . . 1.94 109.95 173.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 93' ' ' PRO . 12.5 m80 9.54 64.47 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 125.842 1.964 . . . . 11.93 113.802 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.32 77.49 1.11 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.791 1.404 . . . . 1.5 114.791 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 96.1 m -33.2 126.83 0.34 Allowed 'General case' 0 N--CA 1.506 2.354 0 O-C-N 124.181 0.926 . . . . 0.22 110.506 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.1 mt -102.03 153.46 19.88 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.866 -1.531 . . . . 0.3 106.866 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.67 118.77 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.525 -1.287 . . . . 0.21 107.525 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -110.77 156.9 20.42 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.56 0.695 . . . . 1.18 109.296 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -124.94 89.64 3.1 Favored 'General case' 0 N--CA 1.493 1.714 1 N-CA-C 97.499 -5.0 . . . . 1.74 97.499 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.4 t -104.18 147.77 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 115.535 1.68 . . . . 0.05 115.535 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -125.16 105.33 9.07 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.149 -2.296 . . . . 1.73 106.735 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.4 tp -74.99 121.76 22.45 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 100.866 -3.753 . . . . 0.04 100.866 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.41 -54.95 3.7 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.385 -0.825 . . . . 0.34 112.905 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -166.36 177.6 6.69 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.775 -1.17 . . . . 7.5 110.314 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.9 mt -112.62 157.27 21.42 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 105.363 -2.088 . . . . 0.44 105.363 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 N--CA 1.502 2.144 0 CA-C-O 116.141 -1.885 . . . . 6.58 109.744 179.862 . . . . . . . . 0 0 . 1 stop_ save_